QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α
<strong></strong><em>The article presents results of study of inhibitor TNF<span class="st"> α</span> — infliximab — on quality of life in patients with juvenile arthritis, refractory to standard immunosuppressive treatment. In 1.5 months after the beginning o...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2009-01-01
|
Series: | Вопросы современной педиатрии |
Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/1113 |